|
US6534051B1
(en)
|
1992-11-20 |
2003-03-18 |
University Of Medicine And Dentistry Of New Jersey |
Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
|
|
WO1995023846A1
(en)
|
1994-03-04 |
1995-09-08 |
University Of Medicine & Dentistry Of New Jersey |
Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
|
|
ATE223701T1
(de)
|
1994-05-31 |
2002-09-15 |
Inex Pharmaceutical Corp |
Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
|
|
AU6691496A
(en)
|
1995-08-01 |
1997-02-26 |
Advanced Therapies, Inc. |
Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
|
|
JPH10313865A
(ja)
|
1997-05-15 |
1998-12-02 |
Deinabetsuku Kenkyusho:Kk |
ヒト補体制御因子が呈示されたベクター
|
|
DE69938931D1
(de)
|
1998-09-23 |
2008-07-31 |
Inst Virologie Teilrechtsfaehi |
Retrovirale partikel, geschützt gegen komplementvermittelte lyse
|
|
US7094398B1
(en)
|
1999-06-01 |
2006-08-22 |
University Of Washington |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
|
|
US6896881B1
(en)
|
1999-09-24 |
2005-05-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
|
AU2001244354A1
(en)
|
2000-03-30 |
2001-10-15 |
Oxford Biomedica (Uk) Limited |
Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for thetreatment of neurological disorders
|
|
AU2001251138A1
(en)
|
2000-03-31 |
2001-10-15 |
Mayo Foundation For Medical Education And Research |
Compositions and methods for tissue specific gene regulation therapy
|
|
AU7061401A
(en)
|
2000-07-05 |
2002-01-14 |
Transgene Sa |
Chimeric promoters for controlling expression in smooth muscle cells
|
|
CA2325088A1
(en)
|
2000-12-01 |
2002-06-01 |
Fusogenix Inc. |
Novel membrane fusion proteins derived from poikilothermic reovirus
|
|
US7041489B2
(en)
|
2001-10-01 |
2006-05-09 |
The Uab Research Foundation |
Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof
|
|
JP2005507927A
(ja)
|
2001-10-30 |
2005-03-24 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
パーキンソン病を処置するための方法および組成物
|
|
EP1497437A4
(en)
|
2002-05-01 |
2005-11-16 |
Cell Genesys Inc |
LENTIVIRAL VECTOR PARTICLES RESISTANT TO THE INACTIVATION OF A COMPLEMENT
|
|
AU2003275581A1
(en)
|
2002-10-24 |
2004-05-13 |
Dnavec Research Inc. |
Method of transferring gene into t cells
|
|
US20060045910A1
(en)
|
2004-09-02 |
2006-03-02 |
Ehringer William D |
Preserved fusogenic vesicles
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
GB0426641D0
(en)
|
2004-12-03 |
2005-01-05 |
Bioactive Protein Delivery The |
Protein delivery system
|
|
EP1838856A4
(en)
|
2005-01-20 |
2010-07-14 |
Agency Science Tech & Res |
PROCESS FOR DELIVERING NUCLEIC ACIDS TO PERIPHERAL NEURONS
|
|
ES2343270T3
(es)
|
2005-04-25 |
2010-07-27 |
Merial Ltd. |
Vacunas contra el virus nipah.
|
|
WO2007005244A1
(en)
|
2005-07-05 |
2007-01-11 |
The Regents Of The University Of California |
Henipavirus receptor and uses thereof
|
|
CA2632628C
(en)
*
|
2005-12-09 |
2016-01-19 |
Ucb Pharma S.A. |
Antibody molecules having specificity for human il-6
|
|
EP2062246A4
(en)
|
2006-08-18 |
2010-09-29 |
Univ North Carolina |
VACCINES AGAINST CHIMARICAL VIRUSES
|
|
EP1975239A1
(en)
|
2006-09-27 |
2008-10-01 |
Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer |
Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening
|
|
WO2008071959A1
(en)
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
HUE033325T2
(en)
*
|
2007-01-05 |
2017-11-28 |
Univ Zuerich |
Anti-beta-amyloid binder antibodies and their use
|
|
PT2254586E
(pt)
|
2008-02-22 |
2015-05-18 |
Agency Science Tech & Res |
Partículas de células estaminais mesenquimais
|
|
US9617548B2
(en)
|
2008-04-22 |
2017-04-11 |
Vib Vzw |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
US9296790B2
(en)
|
2008-10-03 |
2016-03-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for protein delivery
|
|
AU2008363813A1
(en)
|
2008-11-07 |
2010-05-14 |
Children's Hospital Medical Center |
Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems
|
|
US20100210989A1
(en)
|
2008-12-23 |
2010-08-19 |
Janet Lesley Macpherson |
Processing blood
|
|
US9050269B2
(en)
|
2009-03-10 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Protection of virus particles from phagocytosis by expression of CD47
|
|
EP2456786B2
(en)
|
2009-07-24 |
2017-04-19 |
Immune Design Corp |
Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
|
|
WO2011058052A1
(en)
|
2009-11-13 |
2011-05-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Direct protein delivery with engineered microvesicles
|
|
US20160011197A1
(en)
|
2010-05-07 |
2016-01-14 |
Paul G. Walfish |
Methods and Compositions for the Diagnosis of a Thyroid Condition
|
|
EP2476754A1
(en)
|
2011-01-14 |
2012-07-18 |
Bundesrepublik Deutschland, Letztvertreten Durch Den Präsidenten Des Paul-Ehrlich-Instituts |
Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scFv)
|
|
CN103687590A
(zh)
|
2011-04-28 |
2014-03-26 |
Stc·Unm公司 |
用于靶向给药的多孔纳米颗粒支撑脂双层（原始细胞）及其使用方法
|
|
ES2639122T3
(es)
|
2011-05-13 |
2017-10-25 |
Zoetis Services Llc |
Composiciones inmunogénicas de glucoproteína G de virus Hendra y Nipah
|
|
DK2717922T3
(en)
|
2011-06-10 |
2019-01-07 |
Bluebird Bio Inc |
GENERATIVE VECTORS FOR ADDRENOLEUCODYSTROPHY AND ADDRENOMYELONE EUROPE
|
|
JP2013034401A
(ja)
|
2011-08-04 |
2013-02-21 |
Gunma Univ |
アストロサイトで遺伝子を発現させるためのベクター
|
|
US9249426B2
(en)
|
2011-09-29 |
2016-02-02 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Lentiviral vectors pseudotyped with mutant BaEV glycoproteins
|
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
|
EP2615176A1
(en)
|
2012-01-11 |
2013-07-17 |
Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe |
Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells
|
|
WO2013148327A1
(en)
|
2012-03-26 |
2013-10-03 |
The Regents Of The University Of California |
Nipah virus envelope psuedotyped lentiviruses and methods of their use
|
|
US20130273549A1
(en)
|
2012-04-16 |
2013-10-17 |
Board Of Regents, The University Of Texas System |
Detection of extracellular jcv micrornas
|
|
WO2013166503A1
(en)
|
2012-05-04 |
2013-11-07 |
The Regents Of The University Of California |
Broad antiviral therapy with membrane modifying oxysterols
|
|
US20150216903A1
(en)
|
2012-08-10 |
2015-08-06 |
Bluebird Bio, Inc. |
Compounds for improved viral transduction
|
|
EP3415627A1
(en)
|
2012-11-13 |
2018-12-19 |
Codiak BioSciences, Inc. |
Delivery of therapeutic agent
|
|
KR20150131208A
(ko)
*
|
2013-03-13 |
2015-11-24 |
이미지냅 인코포레이티드 |
Cd８에의 항원 결합 구조체들
|
|
GB201313249D0
(en)
|
2013-07-25 |
2013-09-11 |
Isis Innovation |
Method
|
|
EA037503B1
(ru)
|
2014-01-21 |
2021-04-05 |
Анджариум Байосайенсиз Аг |
Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
|
|
US10513710B2
(en)
|
2014-04-18 |
2019-12-24 |
University Of Massachusetts |
Exosomal loading using hydrophobically modified oligonucleotides
|
|
GB201412494D0
(en)
|
2014-07-14 |
2014-08-27 |
Ospedale San Raffaele And Fond Telethon |
Vector production
|
|
WO2016100232A1
(en)
*
|
2014-12-15 |
2016-06-23 |
The Regents Of The University Of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
US10493165B2
(en)
|
2015-01-30 |
2019-12-03 |
The Johns Hopkins University |
Extracellular vesicles for agent delivery
|
|
HK1249528A1
(zh)
|
2015-02-05 |
2018-11-02 |
Ablynx N.V. |
通过c-末端合成半胱氨酸连接的纳米抗体二聚体
|
|
WO2016138525A1
(en)
|
2015-02-27 |
2016-09-01 |
University Of Washington |
Polypeptide assemblies and methods for the production thereof
|
|
WO2016183482A1
(en)
|
2015-05-13 |
2016-11-17 |
Rubius Therapeutics, Inc. |
Membrane-receiver complex therapeutics
|
|
WO2016196350A1
(en)
|
2015-05-29 |
2016-12-08 |
New York University |
Auf1 encoding compositions for muscle cell uptake, satellite cell populations, and satellite cell mediated muscle generation
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
WO2017005923A1
(en)
|
2015-07-09 |
2017-01-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Lentiviral vector expressing membrane-anchored or secreted antibody
|
|
CA2991301A1
(en)
|
2015-07-13 |
2017-01-19 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
US10624849B2
(en)
|
2015-09-28 |
2020-04-21 |
Northwestern University |
Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
|
|
US10729789B2
(en)
|
2016-03-01 |
2020-08-04 |
University Of Virginia Patent Foundation |
Compositions and methods for adeno-associated virus mediated gene expression in myofibroblast-like cells
|
|
CN108884460B
(zh)
|
2016-03-19 |
2023-04-28 |
埃克苏马生物技术公司 |
淋巴细胞转导及其扩增调节的方法与组合物
|
|
US11458097B2
(en)
|
2016-03-30 |
2022-10-04 |
The University Of North Carolina At Chapel Hill |
Biological agent-exosome compositions and uses thereof
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
JP7072807B2
(ja)
|
2016-06-09 |
2022-05-23 |
アルマ・マテール・ストゥディオルム・ウニベルシータ・ディ・ボローニャ |
細胞内増殖のための改変糖タンパク質ｈを有するヘルペスウイルス
|
|
MA45498A
(fr)
|
2016-06-16 |
2019-04-24 |
Memorial Sloan Kettering Cancer Center |
Cellules treg génétiquement modifiées
|
|
CA3030003A1
(en)
|
2016-07-08 |
2018-01-11 |
F1 Oncology, Inc. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
US20180028600A1
(en)
|
2016-07-15 |
2018-02-01 |
Korea Institute Of Science And Technology |
Novel recombinant exosome and use thereof
|
|
CN110073000A
(zh)
|
2016-07-26 |
2019-07-30 |
森迪生物科学公司 |
遗传擦除子
|
|
EP3540056A4
(en)
|
2016-11-10 |
2020-06-03 |
Kaneka Corporation |
METHOD FOR PRODUCING TRANSGENIC CELLS
|
|
WO2018106732A1
(en)
|
2016-12-05 |
2018-06-14 |
Juno Therapeutics, Inc. |
Production of engineered cells for adoptive cell therapy
|
|
WO2018115507A2
(en)
|
2016-12-23 |
2018-06-28 |
Curevac Ag |
Henipavirus vaccine
|
|
EP3346001A1
(en)
*
|
2017-01-06 |
2018-07-11 |
TXCell |
Monospecific regulatory t cell population with cytotoxicity for b cells
|
|
WO2018129563A1
(en)
|
2017-01-09 |
2018-07-12 |
Oisin Biotechnologies |
Fusogenic lipid nanoparticles and methods for manufacturing and use for therapeutic protein production and for treatment
|
|
AU2018208614A1
(en)
|
2017-01-10 |
2019-07-11 |
The General Hospital Corporation |
Modified T cells and methods of their use
|
|
US11576872B2
(en)
|
2017-05-08 |
2023-02-14 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
CN110997013B
(zh)
*
|
2017-07-24 |
2022-09-20 |
瑞泽恩制药公司 |
抗cd8抗体和其用途
|
|
US12365916B2
(en)
|
2017-10-30 |
2025-07-22 |
Miltenyi Biotec B.V. & Co. KG |
Adapter-based retroviral vector system for the selective transduction of target cells
|
|
EP3720502A4
(en)
|
2017-12-07 |
2022-01-19 |
Flagship Pioneering Innovations V, Inc. |
CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF
|
|
US20210038744A1
(en)
|
2018-02-01 |
2021-02-11 |
Bioverativ Therapeutics Inc. |
Use of lentiviral vectors expressing factor viii
|
|
WO2019157316A2
(en)
|
2018-02-12 |
2019-08-15 |
Flagship Pioneering Innovations V, Inc. |
Methods and devices for the isolation of subcellular components
|
|
WO2019157319A1
(en)
|
2018-02-12 |
2019-08-15 |
Flagship Pioneering Innovations V, Inc. |
Devices and methods for delivering material into a biological tissue or cell
|
|
BR112020016570A2
(pt)
|
2018-02-17 |
2020-12-15 |
Flagship Pioneering Innovations V, Inc. |
Composições e métodos para liberação de proteína de membrana
|
|
CA3100050A1
(en)
*
|
2018-05-11 |
2019-11-14 |
Lupagen, Inc. |
Systems and methods for closed loop, real-time modifications of patient cells
|
|
CN112367973A
(zh)
|
2018-05-15 |
2021-02-12 |
旗舰先锋创新V股份有限公司 |
融合剂脂质体组合物和其用途
|
|
CA3105953A1
(en)
|
2018-07-09 |
2020-01-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
SG11202104120VA
(en)
*
|
2018-10-31 |
2021-05-28 |
Delinia Inc |
Multivalent regulatory t cell modulators
|
|
KR20210131991A
(ko)
|
2018-11-14 |
2021-11-03 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
구획-특이적 카고 전달을 위한 조성물 및 방법
|
|
EP3880179A2
(en)
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for cns delivery
|
|
WO2020102503A2
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|
|
US20230048166A1
(en)
|
2018-11-14 |
2023-02-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
EP3893927A1
(en)
|
2018-12-14 |
2021-10-20 |
GlaxoSmithKline Biologicals S.A. |
Heterologous prime boost vaccine compositions and methods
|
|
US20220184200A1
(en)
|
2019-03-21 |
2022-06-16 |
Georgia State University Research Foundation, Inc. |
Virus-like particles and uses thereof
|
|
EP4025698A1
(en)
*
|
2019-09-03 |
2022-07-13 |
Sana Biotechnology, Inc. |
Cd24-associated particles and related methods and uses thereof
|
|
EP4107176A4
(en)
|
2020-02-20 |
2024-03-20 |
Gritstone bio, Inc. |
ANTIGEN-BINDING PROTEINS TARGETING THE SHARED ANTIGEN KKLC-1
|
|
AU2021248815A1
(en)
|
2020-03-31 |
2022-10-13 |
Flagship Pioneering Innovations V, Inc. |
Targeted lipid particles and compositions and uses thereof
|
|
IL298279A
(en)
|
2020-04-17 |
2023-01-01 |
Council Queensland Inst Medical Res |
Immune cells with enhanced function
|
|
CN116157116A
(zh)
|
2020-07-06 |
2023-05-23 |
旗舰先锋创新V股份有限公司 |
用于产生病毒融合体的方法和组合物
|
|
EP3964585A1
(en)
|
2020-09-03 |
2022-03-09 |
Miltenyi Biotec B.V. & Co. KG |
Cd62l specific lentiviral vector particle for targeted transduction of t cell subsets
|
|
KR20230151513A
(ko)
*
|
2021-01-11 |
2023-11-01 |
사나 바이오테크놀로지, 인크. |
Cd8 표적 바이러스 벡터의 용도
|
|
WO2022165262A1
(en)
|
2021-01-28 |
2022-08-04 |
The Broad Institute, Inc. |
Compositions and methods for delivering cargo to a target cell
|
|
JP2024532963A
(ja)
|
2021-04-08 |
2024-09-11 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ８特異的抗体コンストラクト及びその組成物
|
|
IL308836A
(en)
|
2021-05-28 |
2024-01-01 |
Sana Biotechnology Inc |
Lipid Particles Containing Baboon Truncated Endogenous Retrovirus (BAEV) Envelope Glycoprotein and Related Methods and Uses
|
|
EP4448775A1
(en)
|
2021-12-17 |
2024-10-23 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae attachment glycoproteins
|
|
US20250082777A1
(en)
|
2022-01-10 |
2025-03-13 |
Sana Biotechnology, Inc. |
Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
WO2023150518A1
(en)
|
2022-02-01 |
2023-08-10 |
Sana Biotechnology, Inc. |
Cd3-targeted lentiviral vectors and uses thereof
|
|
WO2023150647A1
(en)
|
2022-02-02 |
2023-08-10 |
Sana Biotechnology, Inc. |
Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
WO2023193015A1
(en)
|
2022-04-01 |
2023-10-05 |
Sana Biotechnology, Inc. |
Cytokine receptor agonist and viral vector combination therapies
|
|
US20260027145A1
(en)
|
2022-07-27 |
2026-01-29 |
Sana Biotechnology, Inc. |
Methods of transduction using a viral vector and inhibitors of antiviral restriction factors
|
|
WO2024044655A1
(en)
|
2022-08-24 |
2024-02-29 |
Sana Biotechnology, Inc. |
Delivery of heterologous proteins
|
|
EP4590688A1
(en)
|
2022-09-21 |
2025-07-30 |
Sana Biotechnology, Inc. |
Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof
|
|
WO2024119157A1
(en)
|
2022-12-02 |
2024-06-06 |
Sana Biotechnology, Inc. |
Lipid particles with cofusogens and methods of producing and using the same
|
|
WO2024220560A1
(en)
|
2023-04-18 |
2024-10-24 |
Sana Biotechnology, Inc. |
Engineered protein g fusogens and related lipid particles and methods thereof
|
|
AU2024274792A1
(en)
|
2023-05-23 |
2025-10-23 |
Sana Biotechnology, Inc. |
Tandem fusogens and related lipid particles
|